Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.64 |
| ▸ | PRKACA | P17612 | 2/20 | 0.63 |
| ▸ | MARS1 | P56192 | 1/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.62 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.62 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.62 |
| ▸ | SRC | P12931 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.62 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.62 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.62 |
| ▸ | LDHA | P00338 | 1/20 | 0.62 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.62 |
| ▸ | FBP1 | P09467 | 1/20 | 0.62 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.62 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13345756 | 0.90 | PRKACA (0.64) | AURKAPRKACAMARS1ADORA1P2RY1 | |
| SCHEMBL13869231 | 0.90 | PRKACA (0.69) | AURKAPRKACAMARS1ADORA1P2RY1 | |
| SCHEMBL1066705 | 0.90 | PRKACA (0.66) | AURKAPRKACAMARS1ADORA1P2RY1 | |
| SCHEMBL10586454 | 0.89 | PRKACA (0.67) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL15297005 | 0.89 | PLA2G2A (0.68) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL14178285 | 0.89 | PLA2G2A (0.68) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL6536155 | 0.89 | PRKACA (0.67) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL2790606 | 0.89 | PLA2G2A (0.68) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL16945765 | 0.89 | PLA2G2A (0.68) | PRKACAMARS1ADORA1P2RY1P2RY2 | |
| SCHEMBL15538484 | 0.88 | PRKACA (0.66) | PRKACAMARS1ADORA1P2RY1P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9180111-B2 | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof | CARDAX PHARMA, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-9180111-B2 | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof | CARDAX PHARMA, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-7763649-B2 | Carotenoid analogs or derivatives for controlling connexin 43 expression | CARDAX PHARMACEUTICALS, INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-7763649-B2 | Carotenoid analogs or derivatives for controlling connexin 43 expression | CARDAX PHARMACEUTICALS, INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-7723327-B2 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease | CARDAX PHARMACEUTICALS, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723327-B2 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease | CARDAX PHARMACEUTICALS, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-7691901-B2 | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation | CARDAX PHARMACEUTICALS INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-7691901-B2 | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation | CARDAX PHARMACEUTICALS INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-7592449-B2 | Structural carotenoid analogs for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592449-B2 | Structural carotenoid analogs for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-09-22 | — | — | US | disclosed |
| US-7521584-B2 | Carotenoid analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-7521584-B2 | Carotenoid analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-7375133-B2 | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-7375133-B2 | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-7345091-B2 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-03-18 | — | — | US | disclosed |
| US-7345091-B2 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-03-18 | — | — | US | disclosed |
| US-7320997-B2 | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-01-22 | — | — | US | disclosed |
| US-7320997-B2 | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease | CARDAX PHARMACEUTICALS, INC. (US) | 2008-01-22 | — | — | US | disclosed |
| US-7317008-B2 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury | CARDAX PHARMACEUTICALS, INC. (US) | 2008-01-08 | — | — | US | disclosed |
| US-7317008-B2 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury | CARDAX PHARMACEUTICALS, INC. (US) | 2008-01-08 | — | — | US | disclosed |